Boston Advisors LLC maintained its stake in shares of Hill-Rom Holdings Inc. (NYSE:HRC) during the second quarter, Holdings Channel reports. The institutional investor owned 8,215 shares of the medical technology company’s stock at the end of the second quarter. Boston Advisors LLC’s holdings in Hill-Rom Holdings were worth $414,000 as of its most recent SEC filing.
Several other large investors have also modified their holdings of the company. Acrospire Investment Management LLC purchased a new position in Hill-Rom Holdings during the first quarter valued at $111,000. LS Investment Advisors LLC raised its position in Hill-Rom Holdings by 67.4% in the second quarter. LS Investment Advisors LLC now owns 3,783 shares of the medical technology company’s stock valued at $191,000 after buying an additional 1,523 shares during the last quarter. Oakbrook Investments LLC raised its position in Hill-Rom Holdings by 26.5% in the second quarter. Oakbrook Investments LLC now owns 5,967 shares of the medical technology company’s stock valued at $301,000 after buying an additional 1,250 shares during the last quarter. Parametrica Management Ltd purchased a new position in Hill-Rom Holdings during the second quarter valued at $321,000. Finally, IBM Retirement Fund raised its position in Hill-Rom Holdings by 16.4% in the second quarter. IBM Retirement Fund now owns 6,611 shares of the medical technology company’s stock valued at $334,000 after buying an additional 931 shares during the last quarter. Institutional investors own 83.11% of the company’s stock.
Shares of Hill-Rom Holdings Inc. (NYSE:HRC) traded up 0.08% on Thursday, reaching $61.91. 529,150 shares of the company’s stock were exchanged. Hill-Rom Holdings Inc. has a 52-week low of $42.99 and a 52-week high of $62.43. The company’s 50 day moving average price is $59.73 and its 200-day moving average price is $53.36. The stock has a market cap of $4.05 billion, a P/E ratio of 63.76 and a beta of 1.14.
Hill-Rom Holdings (NYSE:HRC) last released its quarterly earnings data on Thursday, August 4th. The medical technology company reported $0.81 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.76 by $0.05. Hill-Rom Holdings had a return on equity of 16.62% and a net margin of 2.47%. The company earned $655.40 million during the quarter, compared to the consensus estimate of $647.75 million. During the same quarter in the prior year, the firm posted $0.62 earnings per share. The firm’s revenue was up 38.1% compared to the same quarter last year. Equities analysts forecast that Hill-Rom Holdings Inc. will post $3.33 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, September 30th. Stockholders of record on Friday, September 16th were paid a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 1.10%. The ex-dividend date was Wednesday, September 14th. Hill-Rom Holdings’s dividend payout ratio is currently 73.91%.
Several research analysts recently weighed in on the stock. Zacks Investment Research lowered shares of Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research note on Wednesday. KeyCorp reaffirmed a “buy” rating and issued a $59.00 price target on shares of Hill-Rom Holdings in a research note on Thursday, June 23rd. Finally, Morgan Stanley raised shares of Hill-Rom Holdings from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $54.00 to $62.00 in a research note on Thursday, June 16th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $62.20.
About Hill-Rom Holdings
Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.
Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings Inc. (NYSE:HRC).
Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.